We have had some important improvements in the intensive care units (ICU) like high flow oxygen system (HFOS), therapeutic hypothermia, extra corporeal membrane oxygenation (ECMO), extra corporeal carbon dioxide removal (ECCOR), echocardiography (ECHO) and ultrasonography (US).
High flow oxygen system
Traditionally, oxygen delivery systems can be classified as low flow oxygen system (LFOS) and high flow oxygen system (HFOS). If the patient's respiratory demand is met completely by the system, the system is called as high flow oxygen system such as venturi mask. If the patient ventilator demand cannot meet by the oxygen delivery system, the system is called as low flow oxygen system such as nasal cannula, simple mask (Table I) . It is accepted that the adult patient whose tidal volume is between 300-700 mL and whose respiratory rate below 25/ min and whose ventilatory pattern is regular may use LFOS, because the patient will receive consistent and predictable FiO 2 on a LFOS. If any one of these three criteria is not met, the patient should be on HFOS.
HFOS gives oxygen to the patients at rates of flow higher (up to 60 L/min) than that delivered traditionally in LFOS (up to 16L/min). Oxygen flow only shows total gas flow, does not show FiO 2 . FiO 2 delivered by an oxygen flow is determined by the apparatus and the patients. So it can be also got high FiO2 by using LFOS such as mask plus reservoir bag.
The high gas inlet flow prevents secondary roomair entrainments. So, all of the patient's respiratory requirements can be met by HFOS. The air is warmed to 37 °C and humidified. Humidification prevents mucus plugging. Mucociliary function remains well. The warmed and humidified oxygen can be better tolerated by the patient, so patient comfort increases.
High flow washes out CO 2 in anatomic dead space; create high FiO 2 in the anatomic reservoir (nasal cavity, nasopharynx and oropharynx). The warm, humidified constant flow improves gas exchange and reduces respiratory work. PEEP can be generated by HFOS. It is obtained 1 cmH 2 O PEEP for every 10 L/min of flow delivered by HFOS. This may help to prevent and/or decrease atelectasis [1] .
HFOS serve as an important alternative to noninvasive mechanical ventilation especially in the management of the patients with hypoxemic respiratory failure. Noninvasive mechanical ventilation cannot be used in patients with facial, esophageal or gastric surgery, impaired swallowing and cough. A high flow oxygen system uses special nasal cannula thus HFOS does not interfere with eating and speaking. If the patient receives FiO 2 of greater than 60% and more than 48 hours, the patient may at risk of oxygen toxicity. Positive pressure ventilation improves oxygenation and CO 2 removal by alveolar recruitment, increasing alveolar volume and redistribution of extracellular lung water, So it is reasonable to use positive pressure in the patient on high O 2 like this level ( Figure 1 ) [2] . Epistaxis, base of skull fracture, surgery to the nose or upper aero-digestive tract, nasal obstruction; e.g. nasal fracture, tenacious secretions, tumor are main contraindications for HFOS therapy.
High-flow oxygen has been shown to result in better comfort and oxygenation than standard oxygen therapy delivered through a face mask in patients with acute respiratory failure of various origins. In acute cardiogenic pulmonary edema, providing low levels of PEEP, HFOS proposed to function as CPAP through opening collapsed alveoli and enhancing cardiac function through afterload reducing effect of PEEP. A cohort study showed promising results [3] . In postoperative hypoxemic respiratory failure HFOS have shown improved oxygenation, reduced respiratory rate and need for noninvasive mechanical ventilation [4] [5] [6] . Two randomized trials comparing standard oxygen therapy and HFOS have shown a better patient comfort but no significant difference in gas exchange in post-extubation patients [7, 8] . Two retrospective analysis of HFOS in Do-Not-Intubate patients with cancer and respiratory distress have shown that nearly 85% of patients 38 Karakurt et treated with HFOS improved or remained stable but 18% of patients still needed escalation of therapy to NIMV [9, 10] .
It has been reported that treatment with high-flow oxygen improved the survival rate among patients with acute hypoxemic respiratory failure, as compared with standard oxygen therapy or NIMV. The hazard ratio for death at 90 days was 2.01 (95% confidence interval (CI), 1.01 to 3.99) with standard oxygen versus high-flow oxygen (p=0.046) and 2.50 (95% CI, 1.31 to 4.78) with NIMV versus high-flow oxygen (p=0.006).Intubation rates were not significantly different among three groups (38% in the high flow O 2 group, 47% in the low flow O 2 group and 50% in the NIMV group [11] .A prospective trial in patients with hypoxemic respiratory failure, HFOS applied sequentially with non-invasive mechanical ventilation (NIMV) and shown that HFOS improved oxygenation but not as much as NIMV compared to standard oxygen therapy [12] .
In conclusion, HFOS have become standard care in several clinical situations for infants, children and preterm neonates. It has a number of physiologic benefits over conventional therapy such as greater comfort and tolerance, improved oxygenation. So it is gaining clinical use in adult population.
Therapeutic hyperthermia

Therapeutic hypothermia after cardiac arrest
Cardiac arrest is a catastrophic, life threatening event. Survival and neurologic recovery vary widely. Fortunately over the last decade there are improvements in survival and neurologic outcomes due to increased education and awareness of basic cardiac life support and may be more importantly concept of post-resuscitation care.
Post-resuscitation care consists of optimization of oxygenation and ventilation, avoiding hypotension, treating immediate precipitants of cardiac arrest such as acute coronary ischemia and initiating therapeutic (induced) hypothermia (TT or IT). Current guidelines uses the term "Targeted Temperature Management" (TTM) [13] [14] [15] .
During cardiac arrest, hypoxia and eventually anoxia develops. In brain tissue, within minutes ATP and glucose are depleted and cells lose their integrity. This results in apoptosis. Restoration of oxygenation as a result of successful resuscitation stops anoxic injury but death form reperfusion injury occurs. Reperfusion injury is a result of increased reactive oxygen species and with other inflammatory cascades further aggravates endothelial and vasomotor dysfunction, edema, hypoxia at tissue-level in spite of adequate arterial oxygenation, and sequential neurological damage. Hypothermia slowdown inflammatory cascade and inhibits apoptosis pathways by downregulating excitatory amino acids and free radicals. Also, hypothermia decreases cerebral metabolic rate, blood volume, and intracranial pressure [16] .
The Hypothermia After Cardiac Arrest Study Group have shown that in patients who have been successfully resuscitated after cardiac arrest due to ventricular fibrillation, therapeutic mild hypothermia increased the rate of a favorable neurologic outcome and reduced mortality. 55 % of patients had better neurologic outcome and mortality at six months was 41 % in the hypothermia group as compared with 55 % in the normothermia group (RR: 0.74; 95 % CI: 0.58 -0.95) [17] . Also another trial on comatose survivors of out-of-hospital cardiac arrest suggests that treatment with moderate hypothermia appears to improve outcomes in patients. 49 % patients treated with hypothermia survived and had a good outcome as compared with 26 % treated with normothermia (p=0.046). The odds ratio for a good outcome with hypothermia as compared with normothermia was 5.25 (95 % CI: 1.47 -18.76; P=0.011) [18] .
On the basis of these 2 studies, TH/IH/TTM is now considered standard of care in the treatment of patients successfully resuscitated from a ventricular tachycardia (VT/VF) arrest and is recommended as a reasonable option for patients with CA from a non-shockable rhythm.
Current practice guideline recommendations of The American Heart Association, the International Liaison Committee of Resuscitation, and the European Resuscitation Council are summarized in Table II .
Therapeutic hypothermia after traumatic brain injury
Fever aggravates outcome after stroke and head injury, probably by worsening secondary brain injury [19] . TH has become an experimental treatment for traumatic brain injury due to its intracranial pressure reducing and neuroprotective effect [20] . A systematic review of TH following traumatic brain injury has indicated a small decrease in mortality (RR 0.76, 95% CI 0.60-0.97) or poor neurologic outcome (RR 0.69, 95% CI 0.55-0.86) [21] . Later reviews found parallel results for death and neurologic outcome as well as an increased risk for pneumonia [20, [22] [23] [24] [25] [26] . 39 
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Therapeutic hypothermia in acute liver failure
Cerebral edema is a rare but fatal complication of acute liver failure. Its incidence increases with grade of encephalopathy and nearly 75 % of patients with grade IV encephalopathy have cerebral edema [27] . Cerebral edema leads to the most common causes of death in acute liver failure which are elevated intracranial pressure, brain ischemia, and brainstem herniation [28] . Liver transplantation remains the only definitive treatment option for cerebral edema. Animal models of liver failure have shown that hypothermia decreases cerebral edema [29] . A systematic review of case series has shown that induction of moderate hypothermia may have a benefit but only with intracranial pressure monitoring [30] .
However, more recent studies have had variable results [31, 32] . In spite of the potential beneficial effects, hypothermia can also increase the risk of infection, cardiac dysrhythmias and bleeding [33] . Consequently, more studies are needed before TH/IH/TTM can be routinely used. However, it is a reasonable option as a bridge to transplantation as we used previously successfully in our center [34] .
TH consists of 4 stages: initiation, maintenance, rewarming and return to normothermia ( Figure 3 ). There are multiple methods to induce and maintain TH [35] .
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
• comatose (ie, lack of meaningful response to verbal commands) adult patients with ROSC after cardiac arrest should have TTM (Class I, LOE B-R for VF/pVT OHCA; Class I, LOE C-EO for non-VF/pVT (ie, "nonshockable") and in-hospital cardiac arrest).
• selecting and maintaining a constant temperature between 32°C and 36°C during TTM (Class I, LOE B-R)
• maintained for at least 24 hours after achieving target temperature (Class IIa, LOE C-EO)
• We recommend against the routine prehospital cooling of patients after ROSC with rapid infusion of cold intravenous fluids (Class III: No Benefit, LOE A)
• reasonable to actively prevent fever in comatose patients after TTM (Class IIb, LOE C-LD).
European Resuscitation Council Guidelines for Resuscitation
• TTM is recommended for adults after OHCA with an initial shockable rhythm who remain unresponsive after ROSC (strong recommendation, low-quality evidence)
• TTM is suggested for adults after OHCA with an initial non-shockable rhythm who remain unresponsive after ROSC (weak recommendation, very low-quality evidence).
• TTM is suggested for adults after IHCA with any initial rhythm who remain unresponsive after ROSC (weak recommendation, very low-quality evidence)
• Maintain a constant, target temperature between 32 0 C and 36 0 C for those patients in whom temperature control is used (strong recommendation, moderate-quality evidence)
• If targeted temperature management is used, it is suggested that the duration is at least 24 h (weak recommendation, very lowquality evidence).
International Liaison Committee on Resuscitation
• We recommend targeted temperature management as opposed to no targeted temperature management for adults with OHCA with an initial shockable rhythm who remain unresponsive after ROSC (strong recommendation, low-quality evidence).
• We suggest targeted temperature management for adults with OHCA with an initial nonshockable rhythm who remain unresponsive after ROSC (weak recommendation, low-quality evidence).
• We suggest targeted temperature management for adults with IHCA with any initial rhythm who remain unresponsive after ROSC (weak recommendation, very low-quality evidence).
• We recommend selecting and maintaining a constant target temperature between 32°C and 36°C for those patients in whom targeted temperature management is used (strong recommendation, moderate-quality evidence). 
Conventional Cooling Systems:
Ice bags and cold saline infusion are the easiest and cheapest ways to induce hypothermia. They have been shown to be effective in inducing hypothermia but not in maintenance [36] . Also they can be used with other cooling methods [37] . But most important disadvantage of these systems is the uncontrolled cooling which may result in body temperatures below target range.
Surface Cooling Systems:
Circulating cold air or cold fluids inside blankets or pads surrounding body is an effective way of cooling. Advantages include ease of use and rapid initiation of treatment. Also these systems have a computer controlled feedback system and allows user to interfere according to trends. Possible disadvantage of these systems is that skin burns and irritations. Shivers also seen more commonly [35] .
Internal Cooling Systems: These systems use central venous catheters through which cool or warm saline circulates in a closed loop. By means of heat exchange with blood catheters achieve hypothermia and maintain it precisely. In spite of these advantages, compared to surface cooling there is no significant difference in outcome [38] .
Extra Corporeal Membrane Oxygenation (ECMO) and Extra Corporeal Carbon Dioxide Removal (ECCOR)
ECMO has become an essential tool in critical care patients with severe respiratory and cardiac failure, refractory to conventional therapy methods.
The first heart-lung machine was used for cardiovascular surgery in 1953 [39] . Soon after successful use of extracorporeal membrane oxygenation (ECMO) outside the operating room was reported in 1972, by Robert Bartlett [40] . This work led to technologic innovations and use of extracorporeal life support (ECLS) in management of patients with severe acute respiratory distress syndrome (ARDS). 2009 to 2010 influenza (H1N1) pandemics resulted in an increasing use of ECLS for cardiopulmonary failure after traditional treatment options have failed [41] .
ECMO is a type of cardiopulmonary support, where blood is drained from the vascular system via cannula connected to a mechanical circuit outside the body and then reinfused into the circulation with oxygenation and removal of pCO 2 .
Depending on indications there are two types of ECMO with cardiopulmonary (venoarterial VA-ECMO) or pulmonary support (venovenous VV-ECMO). Support can work partially or completely by preference. A typical circuit is composed of cannulas and tubing, a membrane or oxygenator, a blood pump and a heat exchanger. Venous blood drained from a major vein, passes through a pump and a membrane for gas Exchange and then returns a major artery (VA-ECMO) or vein (VVECMO) fully saturated with oxygen through an oxygenator, cleaned from CO 2 via a membrane heated by an exchanger (Figure 4 ). Venoarterial systems support heart and lung, venovenous systems support lung during ECMO. ECCOR (venovenous, lower blood flow rates system with or without pump) supports only lung 41 [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] ECCOR is provided to remove CO 2 and, unlike ECMO, does not provide significant oxygenation. In contrast to ECMO, where the need for oxygenation requires high blood flow rates, ECCOR allows much lower blood flow rates (500-1000mL/min) and needs smaller access cannulas. So, ECCOR promises to improve safety and ease of use. If the patient has sufficient arterial pressure (arteriovenous pressure gradient ≥ 60 mm Hg), a pumpless system may be used in ECCOR. Otherwise, we have to use mechanical pump [42] .
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Vascular access and management
VA is preferred if cardiac function is depressed and cardiac support is also required. Patients with severe respiratory failure and secondary cardiac failure may improve on VV support alone. VV access may be by femoral and jugular veins with 2 cannulas or a double lumen cannula via only jugular vein [43] .
VA access may be central with intrathoracic cannula through ascending aorta in postcardiotomy and percutaneous peripheral with femoral artery to femoral vein or femoral artery to jugular vein in non-postcardiotomy patients [43] . Femoral to femoral access is preferred for VAECMO because insertion is faster and easier in cardiogenic shock patients.
Although depends on the indication and type of ECMO, management based on circuit and patient related factors. Anticoagulation is needed, with a target value ACT or aPTT, to maintain the blood flow in circuit. Hemodynamics is important especially in VV-ECMO, inotropes, vasodilators; blood volume replacement may be needed. Lung protective strategies are used with minimizing support of mechanical ventilator to achieve lung recovery. Minimal to heavy sedation is required according to the stage of the procedure. Positioning and activity, infection control, renal replacement, nutrition and temperature management require special attention.
ECMO is a bridge to; recovery till the resolution of underlying reversible cause (for example; resolve of thrombus in massive pulmonary embolism with severe hypoxemia), implantable circulatory support ventricular assist device (VAD) or transplantation of heart or lung (Table III) . There is no absolute contraindication. Each cause depends on every patient individually with respect to risks and benefits. However, conditions associated with poor outcome despite ECMO can be considered as contraindications (Table IV) . 
Complications of ECMO
Problems could be related to the underlining disease or ECMO mechanics itself. The most common complication is hemorrhage [44] . Surgery required bleeding was reported up to 34% with VA-ECMO and 17% with VV-ECMO [45] . Mainly anticoagulation and hemodilution rarely catheter malposition cause bleeding [46] .Bleeding may occur at cannula side as well as any side of the body and may increase mortality. Mostly pulmonary or intracerebral hemorrhage was reported thorough ARDS patients on ECMO [47] . Treatment requires stopping anticoagulants and infusion of platelets and clotting factors [46] . Hemolysis of blood in the circuit, thrombus or clot formation and systemic thromboembolism and cerebral infarction were also reported in the literature [48, 49] .Catheter and circuit related infections and septic complications may be higher through patients on ECMO. Increased volume of distribution and filtering effect of membranous part of the circuit may alter serum concentration of drugs. Dose alterations may be necessary when narrow therapeutic drugs are administered [50] .
Weaning from ECMO
ECMO support is decreased together with the recovery of underlying disease. When gas flow is minimum at lowest ventilatory settings with improving organ function, weaning protocol is started. As a rule weaning is started at levels less than 30% of total support. Ventilatory settings and vasopressor-inotropes are adjusted support is interrupted for a while and patient is checked for stability. This procedure is called as 'trial off'. After a successful trial off, anticoagulant therapy is stopped and decannulation should be done. If patient seems to need ECMO further again, cannulas can be left 24 hours or more. Decannulation must performed after a successful trial off [43] .
Prognosis
According to data reported by ELSO in January 2015, 65.171patients received ECLS, of total 71% were weaned and59% were discharged or transferred [50] . Underlying cause for ECMO has an importance on survival. In a study, 67%ofARDS patients were reported to be treated successfully with ECMO and survival to hospital discharge was52 % [51] . CESAR study demonstrated that referral to an ECMO center significantly improves recovery and survival from severe ARDS [52] . H1N1-relatedARDS was shown to have lower hospital mortality when referred to an ECMO center (23.7% vs.52.5%) [53] . It has been shown that ECMO performed cardiopulmonary resuscitation was associated with increased survival with minimal neurologic impairment compared to conventional method [54] .
In conclusion, experience with ECMO has been 43 Karakurt et [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] improving with better survival rates and decreasing morbidity. Considering ECMO for patients with respiratory failure or heart failure when conventional therapies failed, if the underlying pathology is reversible or as a bridge to heart and/or lung transplantation is important.
Ultrasound in critical care
Advances in technology have led ultrasound (US) use through non-radiologist physicians at bedside. A noninvasive, dynamic-real time tool that has no radiation risk may be valuable for critically ill for whom timely, efficient bedside diagnostics are essential.
Critical care ultrasonography (CCUS) has utility for intensivist-performed, immediate diagnoses of life threatening diseases, with no need to transport patients to radiology departments or wait for radiologist or cardiologist on a consultative basis. Because of the principle of focused assessments, it differs from traditional US examinations where time-consuming full regional scans are performed.
Additionally, the intensivist can repeat the examination to evaluate the effects of therapy and direct the management of the critical condition. Goal-directed and repeated US allows Intensive Care Unit (ICU) physician to diagnose and monitor the condition of the patient on a methodical basis.
Components of critical care ultrasonography
The [55] According to American Committee on Graduate Medical Education; US is a mandatory part of critical care fellowship training in the United States as from July 1, 2014 [56] .
Consequently, CCUS and echocardiography should be an essential part of training of every ICU physician.
Thoracic ultrasonography
A recent field of CCUS is examination of the lung and pleura. Portability, absence of radiation, ability to repeat at bedside make lung US more applicable than chest x-ray or computed tomography (CT).
A variety of pathologies like pleural effusion, pneumothorax, atelectasis, pneumonia and alveolarinterstitial syndrome can be detected easily and quickly by sonographic examination of thorax. Compared with chest x-ray, US has high sensitivity and specificity rates for detection of pleural [57, 58] and parenchymal [59] [60] [61] [62] diseases of lungs. (Table V) (Figures 5, 6, 7, 8, 9 ). On the other hand, there are some disadvantages of performing thoracic US. It is notably that, almost all of the pathologies detected on US are superficial. When it comes to deeper parenchymal pathologies, US may be an inadequate tool compared with CT. Since results are operator dependent, different diagnoses between physicians may be confusing. This disadvantage itself reflects the importance of an adequate, standard and supervised training program for ICU physicians.
Abdominal ultrasound
Abdominal free fluid, causes of post-renal acute renal failure and however rarely, pathologies of retroperitoneum and major abdominal vessels can be detected early by focused US assessments, especially in hemodynamically unstable critically ill. It has been shown in the critically ill that renal vasoconstriction can reduce renal blood flow to 50% of normal [63] . Daily monitoring renal perfusion via Doppler US in shock is a recent, ongoing research.
Transcranial Doppler (TCD)
Cerebral blood supply can be calculated using the Doppler US to support the diagnosis of brain death, vasospasm or ischemic stroke. TCD also helps to monitor the effects of therapeutic intervention of intracranial pathologies. It may help to diagnose brain death with a sensitivity of 76% and specificity of 74.3 % [64] .
Ocular US
A direct relation has been documented between the subarachnoid space of the optic nerve and the chiasmal cistern of the brain. When ICP increases, cerebrospinal fluid flows towards the perineural subarachnoid space and results in expansion of the optic nerve sheath diameter (ONSD). Measurement of ONSD is useful to monitor intracranial pressure (ICP). A diameter of >5 mm has been shown to correlate with increased ICP shown on CT with a sensitivity of 100% and specificity 95%, respectively ( Figure 10 ) [65] . 
Other uses of critical ultrasound ara başlık
Additionally US helps to detect; DVT, muscle wasting due to critical illness, edema of tracheal wall with smoke inhalation, position of endotracheal tube, gastric volume assessment in patients with nasoduodenal enteral feeding in critically ill.
It also can be used to guide vascular access, thoracentesis, pericardiocentesis, paracentesis, percutaneous tracheostomy and regional anesthesia.
Critical care echocardiography
According to the ACCP/SRLF Statement, critical care echocardiography (CCE) can be performed on two levels methodically: basic and advanced [55] . While basic CCE can be learned in a relatively short training period with a limited number of transthoracic echocardiography (TTE) views, advanced CCE requires an improved skill level in both TTE and transesophageal echocardiography (TEE) and a much longer duration of training.
Reversible causes of shock or cardiac like cardiac tamponade, left ventricular failure, ventricular wall motion abnormalities, massive pulmonary embolism, infective endocarditis, intracardiac thrombi or aortic dissections can be detected immediately via '' basic'' or "focused" or "goal-directed" echocardiography, in critically ill patients. (Figure 1 ) Additionally, fluid responsiveness of patients on admission can easily be determined in shock states. Goaldirected echocardiography has been proven to, not only improve clinical diagnosis and but also management of acute critical illness (Table VI) [66] . A detailed assessment of stroke volume (SV),pulmonary pressures, left atrial pressure, valvular function and the great vessels (aorta and pulmonary artery) requires an advanced examination and recognition of an abnormal situation should prompt a detailed assessment by a cardiologist.
Since noninvasive estimation of LV filling pressures with echocardiography is possible, invasive placement of pulmonary artery catheter has decreased. A Doppler index, named E/Ea correlates significantly with invasively derived mean pulmonary capillary wedge pressure. Generally, an E/ Ea>10 is predictive of a mean pulmonary capillary wedge pressure above 15 mmHg with a sensitivity and specificity of 92 and 80 percent, respectively [67] .
Diameter of VCI may help to have an idea about volume status of critically ill. Although it does not accurately reflect central venous pressure; respiratory variability IVC diameter has been described as a noninvasive method for determining fluid responsiveness [68] (Figure 2 ) For example, If the VCI diameter is less than 2.1 cm and there is 50% collapse during respiration, it means that the patient has low volume status.
In conclusion, portable, repeatable, relatively inexpensive, painless, x-ray free and safe US examination is a practical approach to diagnose, manage and follow up of the critical illness. Sonographic examination should be a part of daily routine work of intensivists to improve morbidity and survival rates.
